EE9800141A - Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena - Google Patents

Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena

Info

Publication number
EE9800141A
EE9800141A EE9800141A EE9800141A EE9800141A EE 9800141 A EE9800141 A EE 9800141A EE 9800141 A EE9800141 A EE 9800141A EE 9800141 A EE9800141 A EE 9800141A EE 9800141 A EE9800141 A EE 9800141A
Authority
EE
Estonia
Prior art keywords
amidine
nitric oxide
oxide synthase
synthase inhibitors
isothiourea derivatives
Prior art date
Application number
EE9800141A
Other languages
English (en)
Inventor
Macdonald James
Shakespeare William
Matz James
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9600275A external-priority patent/SE9600275D0/xx
Priority claimed from SE9603300A external-priority patent/SE9603300D0/xx
Priority claimed from SE9603301A external-priority patent/SE9603301D0/xx
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9800141A publication Critical patent/EE9800141A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Treating Waste Gases (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Gas Separation By Absorption (AREA)
EE9800141A 1995-11-07 1996-11-06 Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena EE9800141A (et)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US625395P 1995-11-07 1995-11-07
US627695P 1995-11-07 1995-11-07
SE9600275A SE9600275D0 (sv) 1996-01-25 1996-01-25 Compounds
SE9603300A SE9603300D0 (sv) 1996-09-11 1996-09-11 Compounds
SE9603301A SE9603301D0 (sv) 1996-09-11 1996-09-11 Compounds and compositions
PCT/SE1996/001425 WO1997017344A1 (en) 1995-11-07 1996-11-06 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase

Publications (1)

Publication Number Publication Date
EE9800141A true EE9800141A (et) 1998-10-15

Family

ID=27532790

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800141A EE9800141A (et) 1995-11-07 1996-11-06 Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena

Country Status (24)

Country Link
EP (1) EP0861250B1 (et)
JP (1) JP2000500132A (et)
KR (1) KR19990067349A (et)
AT (1) ATE213241T1 (et)
AU (1) AU701329B2 (et)
BR (1) BR9611276A (et)
CA (1) CA2235301A1 (et)
CZ (1) CZ139298A3 (et)
DE (1) DE69619259T2 (et)
DK (1) DK0861250T3 (et)
EE (1) EE9800141A (et)
ES (1) ES2171743T3 (et)
HU (1) HUP9900142A3 (et)
IL (1) IL124296A0 (et)
IS (1) IS4725A (et)
NO (1) NO982072L (et)
NZ (1) NZ322227A (et)
PL (1) PL326554A1 (et)
PT (1) PT861250E (et)
SI (1) SI0861250T1 (et)
SK (1) SK61098A3 (et)
TR (1) TR199800813T2 (et)
TW (1) TW458978B (et)
WO (1) WO1997017344A1 (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4947197A (en) * 1996-10-16 1998-05-11 Glaxo Group Limited Tetrahydro-6h-pyrazino{1,2-b}isoquinoline 1,4-diones as apoprotein b-100 inhibitors
SE9701681D0 (sv) * 1997-05-05 1997-05-05 Astra Ab New compounds
SE9901901D0 (sv) * 1999-05-26 1999-05-26 Astra Ab Compounds
WO2003051869A1 (en) * 2001-12-19 2003-06-26 H. Lundbeck A/S 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
US6608193B2 (en) * 2001-12-21 2003-08-19 The Procter & Gamble Company Methods for synthesis of amino-tetrahydroisoquinoline ring compounds
DK1539724T3 (da) * 2002-08-07 2008-02-11 Neuraxon Inc Aminobenzothiazolforbindelser med NOS-inhiberende aktivitet
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
JP2009501705A (ja) * 2005-07-05 2009-01-22 アストラゼネカ・アクチエボラーグ 新規化合物、その製造方法、中間体、医薬組成物、並びにアルツハイマー病、認知障害、統合失調症に伴う認識機能障害、肥満及びパーキンソン病のような5−ht6介在疾患の治療におけるそれらの使用
WO2008108445A1 (ja) 2007-03-07 2008-09-12 Takeda Pharmaceutical Company Limited ベンゾオキサゼピン誘導体およびその用途
CA3045492C (en) 2016-12-23 2021-10-19 Daiichi Sankyo Company, Limited Sulfonamide compounds having tnap inhibitory activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE180255T1 (de) * 1993-03-23 1999-06-15 Astra Ab Guanidinderivate mit therapeutischer wirkung
PL180081B1 (pl) * 1993-08-12 2000-12-29 Astra Ab Nowe pochodne amidyny i sposób ich wytwarzania PL PL PL PL PL PL PL
EP0723438A1 (en) * 1993-10-04 1996-07-31 The Wellcome Foundation Limited Substituted urea and isothiourea derivatives as no synthase inhibitors
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy

Also Published As

Publication number Publication date
AU701329B2 (en) 1999-01-28
TR199800813T2 (xx) 1998-07-21
PT861250E (pt) 2002-07-31
DK0861250T3 (da) 2002-04-29
WO1997017344A1 (en) 1997-05-15
EP0861250A1 (en) 1998-09-02
EP0861250B1 (en) 2002-02-13
CA2235301A1 (en) 1997-05-15
JP2000500132A (ja) 2000-01-11
HUP9900142A3 (en) 2001-08-28
KR19990067349A (ko) 1999-08-16
AU7592796A (en) 1997-05-29
SK61098A3 (en) 1999-01-11
DE69619259D1 (de) 2002-03-21
ATE213241T1 (de) 2002-02-15
MX9803453A (es) 1998-09-30
IL124296A0 (en) 1998-12-06
PL326554A1 (en) 1998-09-28
SI0861250T1 (en) 2002-06-30
NO982072L (no) 1998-07-03
ES2171743T3 (es) 2002-09-16
CZ139298A3 (cs) 1998-09-16
DE69619259T2 (de) 2002-09-19
NZ322227A (en) 1999-11-29
IS4725A (is) 1998-04-24
HUP9900142A2 (hu) 1999-05-28
BR9611276A (pt) 1999-01-26
NO982072D0 (no) 1998-05-06
TW458978B (en) 2001-10-11

Similar Documents

Publication Publication Date Title
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO996108L (no) 9-oksinerytromycinderivater
SE0302323D0 (sv) Novel compounds
SE9803518D0 (sv) Novel compounds
NO984470L (no) Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
EE9800141A (et) Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena
SE9803773D0 (sv) Compounds
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
DK0490816T3 (da) Fluorforbindelser som aromatase-inhibitorer.
DK624989D0 (da) Hidtil ukendte forbindelser
DE69330601D1 (de) Serotoninergische ergolin derivate
TR199902720T2 (xx) Nitrik oksit sentaz�n�n inhibit�rleri olarak amidin t�revleri.
SE9901901D0 (sv) Compounds
SE9904676D0 (sv) Novel compounds
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
CO5261624A1 (es) Novedosos derivados fenilheteroalquilamina, procesos para su preparacion, composiciones farmaceuticas que comprenden dichos derivados novedosos y su uso en terapia
SE0102640D0 (sv) Novel compounds
SE9904677D0 (sv) Novel compounds
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
SE0000477D0 (sv) Novel compounds
SE9802650D0 (sv) Compounds